Description
Altiratinib is an inhibitor of c-MET, Tie-2, and VEGFR that exhibits anticancer chemotherapeutic activity. In ovarian cancer models, this compound inhibits cell growth and migration and decreases tumor burden.
Product Unit Size | Cost | Quantity | Stock |
---|
Altiratinib is an inhibitor of c-MET, Tie-2, and VEGFR that exhibits anticancer chemotherapeutic activity. In ovarian cancer models, this compound inhibits cell growth and migration and decreases tumor burden.
Cas No. | 1345847-93-9 |
---|---|
Purity | ≥98% |
Formula | C26H21F3N4O4 |
Formula Wt. | 510.46 |
Chemical Name | 1-N'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
IUPAC Name | N-[4-({2-[(Cyclopropylcarbonyl)amino]-4-pyridinyl}oxy)-2,5-difluorophenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide |
Synonym | DCC-2701, DP-5164 |
Solubility | DMSO: 33mg/mL |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Kwon Y, Smith BD, Zhou Y, et al. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015 Jan 8;34(2):144-53. PMID: 24362531.
Recombinant protein containing Treponema pallid...
Pyrimidine analog, fluorouracil derivative; thy...
NS3/4A inhibitor
Endogenous bombesin-like peptide, involved in f...
Diterpene found in Rosmarinus.
Iron chelator.
Produced by Aspergillus; type 2 methionine amin...
Endogenous peptide, produced by activation of P...
Azoxy compound
Endogenous peptide fragment, involved in vasoco...
Peptide; α4β1 integrin activator.
Histamine H1 antagonist.
HIV protease inhibitor, SERCA inhibitor.
Methylated derivative of n-octyl-caffeate.
D2 and D4 dopamine receptor inhibitor.
Platelet substitute, peptide; GP IIb/IIIa activ...
Synthetic ITC.
Type A trichothecene mycotoxin produced by Fusa...
Fluoroquinolone; topoisomerase IV and bacterial...
Endogenous peptide, cleavage product of angiote...